Salynt Inc. Information

Salynt is a Maryland-based healthcare AI company building SmartMed, an advanced neuroimaging platform for brain tumor care and research. SmartMed is designed to transform complex MRI data into structured, reproducible evidence through AI-assisted tumor segmentation, volumetric analysis, longitudinal comparison, and advanced 3D visualization. Our goal is simple: give neuro-oncology teams a clearer way to understand what is changing, measure it consistently, and bring that evidence into clinical and research workflows. We are advancing SmartMed toward clinical validation while building the security, compliance, hospital integration, and regulatory infrastructure required for responsible deployment in healthcare. Salynt was born from a deeply personal mission and built around a much larger one: bring clarity to complex healthcare decisions and ultimately impact 100 million lives. We’re building for the clinicians, researchers, health systems, patients, and families who need better answers.